Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer

Marini, Cecilia; Salani, Barbara; Massollo, Michela; Amaro, Adriana; Esposito, Alessia Isabella; Orengo, Anna Maria; Capitanio, Selene; Emionite, Laura; Riondato, Mattia; Bottoni, Gianluca; Massara, Cinzia; Boccardo, Simona; Fabbi, Marina; Campi, Cristina; Ravera, Silvia; Angelini, Giovanna; Morbelli, Silvia; Cilli, Michele; Cordera, Renzo; Truini, Mauro
November 2013
Cell Cycle;11/15/2013, Vol. 12 Issue 22, p3490
Academic Journal
No abstract available.


Related Articles

  • Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II. Salani, Barbara; Marini, Cecilia; Rio, Alberto Del; Ravera, Silvia; Massollo, Michela; Orengo, Anna Maria; Amaro, Adriana; Passalacqua, Mario; Maffioli, Sara; Pfeffer, Ulrich; Cordera, Renzo; Maggi, Davide; Sambuceti, Gianmario // Scientific Reports;6/28/2013, p1 

    The anti-hyperglycaemic drug metformin has important anticancer properties as shown by the direct inhibition of cancer cells proliferation. Tumor cells avidly use glucose as a source for energy production and cell building blocks. Critical to this phenotype is the production of...

  • Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Scotland, S; Saland, E; Skuli, N; de Toni, F; Boutzen, H; Micklow, E; Sénégas, I; Peyraud, R; Peyriga, L; Théodoro, F; Dumon, E; Martineau, Y; Danet-Desnoyers, G; Bono, F; Rocher, C; Levade, T; Manenti, S; Junot, C; Portais, J-C; Alet, N // Leukemia (08876924);Nov2013, Vol. 27 Issue 11, p2129 

    Previous reports demonstrate that metformin, an anti-diabetic drug, can decrease the risk of cancer and inhibit cancer cell growth. However, its mechanism in cancer cells is still unknown. Metformin significantly blocks cell cycle and inhibits cell proliferation and colony formation of leukemic...

  • Targeting cancer cell metabolism: The combination of metformin and 2-Deoxyglucose regulates apoptosis in ovarian cancer cells via p38 MAPK/JNK signaling pathway. Jie Zhu; Ya Zheng; Haiyan Zhang; Hong Sun // American Journal of Translational Research;2016, Vol. 8 Issue 11, p4812 

    Targeting cancer cell metabolism is a new promising strategy to fight cancer. Metformin, a first-line treatment for type 2 diabetes mellitus, exerts anti-cancer and anti-proliferative action. 2-deoxyglucose (2-DG), a glucose analog, works as a competitive inhibitor of glycolysis. In this study,...

  • Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis. Furtado, Cristiane M.; Marcondes, Mariah C.; Sola-Penna, Mauro; Souza, Maisa L. S. de; Zancan, Patricia // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: Clotrimazole is an azole derivative with promising anti-cancer effects. This drug interferes with the activity of glycolytic enzymes altering their cellular distribution and inhibiting their activities. The aim of the present study was to analyze the effects of clotrimazole on the...

  • The Incidence and Repetition of Hospital-Treated Deliberate Self Harm: Findings from the World's First National Registry. Perry, Ivan J.; Corcoran, Paul; Fitzgerald, Anthony P.; Keeley, Helen S.; Reulbach, Udo; Arensman, Ella // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: Suicide is a significant public health issue with almost one million people dying by suicide each year worldwide. Deliberate self harm (DSH) is the single most important risk factor for suicide yet few countries have reliable data on DSH. We developed a national DSH registry in the...

  • Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions. Silvestri, Alessandra; Palumbo, Francesco; Rasi, Ignazio; Posca, Daniela; Pavlidou, Theodora; Paoluzi, Serena; Castagnoli, Luisa; Cesareni, Giovanni // PLoS ONE;8/20/2015, Vol. 10 Issue 8, p1 

    Introduction: Metformin is proposed as adjuvant therapy in cancer treatment because of its ability to limit cancer incidence by negatively modulating the PI3K/AKT/mTOR pathway. In vitro, in addition to inhibiting cancer cell proliferation, metformin can also induce apoptosis. The molecular...

  • Mechanisms by Which Low Glucose Enhances the Cytotoxicity of Metformin to Cancer Cells Both In Vitro and In Vivo. Zhuang, Yongxian; Chan, Daniel K.; Haugrud, Allison B.; Miskimins, W. Keith // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Different cancer cells exhibit altered sensitivity to metformin treatment. Recent studies suggest these findings may be due in part to the common cell culture practice of utilizing high glucose, and when glucose is lowered, metformin becomes increasingly cytotoxic to cancer cells. In low glucose...

  • P17.39 TURN OLD INTO NEW: METFORMIN AS ANTINEOPLASTIC AGENT IN GLIOBLASTOMA. Seliger, C.; Renner, K.; Kreutz, M.; Meyer, A.; Jachnik, B.; Bogdahn, U.; Vollmann-Zwerenz, A.; Hau, P. // Neuro-Oncology;Sep2014 Supplement, Vol. 16 Issue suppl_2, pii96 

    Metformin is one of the most widely prescribed oral antidiabetic drugs. In addition to its known hypoglycemic effects there is current evidence, that metformin may also reduce the risk and mortality of cancer in diabetic patients. The antineoplastic role of metformin has been extensively studied...

  • Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review). HARUKO IRIE; KOUJI BANNO; MEGUMI YANOKURA; MIHO IIDA; MASATAKA ADACHI; KANAKO NAKAMURA; KIYOKO UMENE; YUYA NOGAMI; KENTA MASUDA; YUSUKE KOBAYASHI; EIICHIRO TOMINAGA; DAISUKE AOKI // Oncology Letters;Feb2016, Vol. 11 Issue 2, p1287 

    Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves the enhancement of phosphorylation of liver...

  • Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. Karnevi, Emelie; Said, Katarzyna; Andersson, Roland; Rosendahl, Ann H // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Epidemiological studies have shown direct associations between type 2 diabetes and obesity, both conditions associated with hyperglycaemia and hyperinsulinemia, and the risk of pancreatic cancer. Up to 80% of pancreatic cancer patients present with either new-onset type 2 diabetes or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics